Research Analysts Offer Predictions for Avantor Q1 Earnings

Avantor, Inc. (NYSE:AVTR) – Stock analysts at Zacks Research cut their Q1 2025 earnings per share estimates for Avantor in a report released on Wednesday, February 5th. Zacks Research analyst D. Dey now forecasts that the company will post earnings of $0.24 per share for the quarter, down from their prior estimate of $0.25. The consensus estimate for Avantor’s current full-year earnings is $0.98 per share. Zacks Research also issued estimates for Avantor’s Q2 2025 earnings at $0.26 EPS, Q3 2025 earnings at $0.27 EPS, Q4 2025 earnings at $0.30 EPS, FY2025 earnings at $1.08 EPS, Q4 2026 earnings at $0.35 EPS and FY2026 earnings at $1.23 EPS.

Other analysts also recently issued reports about the company. Robert W. Baird reduced their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, October 28th. Wells Fargo & Company reduced their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Raymond James reduced their price objective on Avantor from $29.00 to $26.00 and set an “outperform” rating for the company in a research note on Tuesday, January 21st. UBS Group reaffirmed a “neutral” rating and set a $25.00 price objective (down from $29.00) on shares of Avantor in a research note on Friday, January 17th. Finally, Barclays upped their price objective on Avantor from $25.00 to $26.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat, Avantor presently has an average rating of “Moderate Buy” and a consensus price target of $27.46.

Avantor Stock Down 11.8 %

Avantor stock opened at $19.15 on Friday. Avantor has a fifty-two week low of $19.08 and a fifty-two week high of $28.00. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. The company has a market capitalization of $13.03 billion, a P/E ratio of 41.63, a PEG ratio of 3.97 and a beta of 1.28. The stock has a 50-day simple moving average of $21.76 and a 200-day simple moving average of $23.46.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.24% and a net margin of 4.54%. During the same quarter in the previous year, the business posted $0.22 earnings per share.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Louisiana State Employees Retirement System grew its holdings in Avantor by 0.3% during the fourth quarter. Louisiana State Employees Retirement System now owns 188,900 shares of the company’s stock worth $3,980,000 after acquiring an additional 500 shares during the period. Hantz Financial Services Inc. lifted its holdings in shares of Avantor by 2.1% during the 3rd quarter. Hantz Financial Services Inc. now owns 24,900 shares of the company’s stock valued at $644,000 after buying an additional 503 shares during the last quarter. Blue Trust Inc. lifted its holdings in shares of Avantor by 6.9% during the 4th quarter. Blue Trust Inc. now owns 8,069 shares of the company’s stock valued at $170,000 after buying an additional 522 shares during the last quarter. Pacer Advisors Inc. lifted its holdings in shares of Avantor by 0.5% during the 4th quarter. Pacer Advisors Inc. now owns 99,825 shares of the company’s stock valued at $2,103,000 after buying an additional 542 shares during the last quarter. Finally, Veracity Capital LLC lifted its holdings in shares of Avantor by 1.0% during the 3rd quarter. Veracity Capital LLC now owns 52,359 shares of the company’s stock valued at $1,355,000 after buying an additional 543 shares during the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.